![J. Frank Harmon](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
J. Frank Harmon
Keine laufenden Positionen mehr
Karriereverlauf von J. Frank Harmon
Ehemalige bekannte Positionen von J. Frank Harmon
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
SAGENT PHARMACEUTICALS INC | Geschäftsführer | 14.03.2016 | 01.10.2018 |
Abraxis BioScience, Inc. /Old/
![]() Abraxis BioScience, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Abraxis BioScience, Inc. manufactures specialty pharmaceutical products. The company develops, manufactures and markets injectable products and leverages revolutionary technology such as its nab(TM) platform to discover and deliver breakthrough therapeutics that transform the treatment of cancer and other life threatening diseases. The company is located in Schaumburg, IL | Geschäftsführer | 01.09.2006 | 15.11.2007 |
CARDINAL HEALTH, INC. | Corporate Officer/Principal | 01.03.2000 | 01.04.2006 |
Abraxis Pharmaceutical Products
![]() Abraxis Pharmaceutical Products Medical SpecialtiesHealth Technology Abraxis Pharmaceutical Products provides injectible pharmaceutical products. It offers anti-infective, critical care, oncology and anesthetic/analgesic products. The company is located in Schaumburg, IL. | Geschäftsführer | 01.09.2006 | - |
Fresenius Kabi Pharmaceuticals Holding LLC
![]() Fresenius Kabi Pharmaceuticals Holding LLC Pharmaceuticals: MajorHealth Technology Fresenius Kabi Pharmaceuticals Holding LLC is a pharmaceutical company, which engages in the development, manufacturing, and marketing of injectable pharmaceutical products. It primarily focuses on the injectable oncology, anti-infective, anesthetic/analgesic, and critical care markets. The firm manufactures products in each of the three basic forms, which include liquid, powder, and lyophilized or freeze-dried. Its products are generally used in hospitals, long-term care facilities, alternate care sites and clinics. The company was founded on July 2, 2008 and is headquartered in Wilmington, DE. | Geschäftsführer | 08.06.2010 | - |
Aventis Behring | Corporate Officer/Principal | - | - |
APP Pharmaceuticals, Inc.
![]() APP Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology APP Pharmaceuticals, Inc. develops, manufactures and markets injectable pharmaceutical products with a primary focus on the oncology, anti-infective, anesthetic/analgesic and critical care markets. It offers one of the most comprehensive product portfolios used in hospitals, long-term care facilities, alternate care sites and clinics within North America and manufactures a comprehensive range of dosage formulations. The company is headquartered in Los Angeles, CA. | Geschäftsführer | 01.04.2006 | - |
Ausbildung von J. Frank Harmon
St. Louis University | Masters Business Admin |
University of Western Kentucky | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 9 |
Spanien | 2 |
Operativ
Chief Operating Officer | 5 |
Corporate Officer/Principal | 2 |
Masters Business Admin | 1 |
Sektoral
Health Technology | 7 |
Consumer Services | 3 |
Distribution Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
CARDINAL HEALTH, INC. | Distribution Services |
Private Unternehmen | 6 |
---|---|
Abraxis BioScience, Inc. /Old/
![]() Abraxis BioScience, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Abraxis BioScience, Inc. manufactures specialty pharmaceutical products. The company develops, manufactures and markets injectable products and leverages revolutionary technology such as its nab(TM) platform to discover and deliver breakthrough therapeutics that transform the treatment of cancer and other life threatening diseases. The company is located in Schaumburg, IL | Health Technology |
APP Pharmaceuticals, Inc.
![]() APP Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology APP Pharmaceuticals, Inc. develops, manufactures and markets injectable pharmaceutical products with a primary focus on the oncology, anti-infective, anesthetic/analgesic and critical care markets. It offers one of the most comprehensive product portfolios used in hospitals, long-term care facilities, alternate care sites and clinics within North America and manufactures a comprehensive range of dosage formulations. The company is headquartered in Los Angeles, CA. | Health Technology |
Aventis Behring | Health Technology |
Fresenius Kabi Pharmaceuticals Holding LLC
![]() Fresenius Kabi Pharmaceuticals Holding LLC Pharmaceuticals: MajorHealth Technology Fresenius Kabi Pharmaceuticals Holding LLC is a pharmaceutical company, which engages in the development, manufacturing, and marketing of injectable pharmaceutical products. It primarily focuses on the injectable oncology, anti-infective, anesthetic/analgesic, and critical care markets. The firm manufactures products in each of the three basic forms, which include liquid, powder, and lyophilized or freeze-dried. Its products are generally used in hospitals, long-term care facilities, alternate care sites and clinics. The company was founded on July 2, 2008 and is headquartered in Wilmington, DE. | Health Technology |
Abraxis Pharmaceutical Products
![]() Abraxis Pharmaceutical Products Medical SpecialtiesHealth Technology Abraxis Pharmaceutical Products provides injectible pharmaceutical products. It offers anti-infective, critical care, oncology and anesthetic/analgesic products. The company is located in Schaumburg, IL. | Health Technology |
Sagent Pharmaceuticals, Inc.
![]() Sagent Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sagent Pharmaceuticals, Inc. engages in the developing, manufacturing, and marketing of medical products. It offers injectable products such as amikacin sulfate, ampicillin and sulbactam, cefazolin, piperacillin and tazobactam, and vancomycin hydrochloride. The company was founded by Jeffrey M. Yordon in 2006 and is headquartered in Schaumburg, IL. | Health Technology |
- Börse
- Insiders
- J. Frank Harmon
- Erfahrung